Clinical & Patient Education Roundtable
Immuno-Oncology
View the Live-Streaming Webcast:
Roundtable Agenda – May 24, 2016:
2:30-2:45pm | Welcome & Introductory Remarks
Ryan Hohman, J.D., Managing Director, Policy & Public Affairs, Friends of Cancer Research
Morrie Ruffin, Co-Founder & Managing Director, Alliance for Regenerative Medicine
2:45-3:30pm | Fireside Chat: The Clinician & Patient Relationship
Jamie Goldfarb, Melanoma Survivor & Patient Advocate; Research Advocate, National Cancer Institute
Steven Rosenberg, M.D., Ph.D., Chief, Surgery Branch; Senior Investigator; Head, Tumor Immunology Section, Center for Cancer Research, National Cancer Institute
3:30-4:30pm | Immuno-Oncology in Cell & Gene Therapies
A multi-stakeholder panel laying the groundwork for an in-depth policy discussion
Tina Albertson, M.D., Ph.D., Medical Director, Juno Therapeutics
Renier Brentjens, M.D., Ph.D., Director, Cell Therapy Center, Memorial Sloan Kettering Cancer Center
Shawn Leland, Pharm. D., Senior Director, Corporate Development and Strategy, Argos Therapeutics
Kimberly Noonan, Ph.D., Research Associate, Johns Hopkins School of Medicine
Madhusudan Peshwa, Ph.D., Chief Scientific Officer, Executive Vice President, Cellular Therapies, MaxCyte
Isabelle Rivière, Ph.D., Director, Cell Therapy and Cell Engineering Laboratory, Memorial Sloan Kettering Cancer Center
4:30-4:45pm | Afternoon Break
4:45-5:45pm | The Three P’s: Politics, Policy & PDUFA
A multi-stakeholder panel discussion featuring leaders from Capitol Hill, cancer research organizations and regulators
Jeff Allen, Ph.D., Executive Director, Friends of Cancer Research
Raj Puri, M.D., Ph.D., Director, Division of Cellular and Gene Therapies, Office of Cellular, Tissue and Gene Therapies, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA)
Marc Theoret, M.D., Lead Medical Officer, Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA)
Michael Werner, J.D., Co-Founder & Executive Director, Alliance for Regenerative Medicine
5:45-6:00pm | Closing Discussion
Ryan Hohman, J.D., Managing Director, Policy & Public Affairs, Friends of Cancer Research
Morrie Ruffin, Co-Founder & Managing Director, Alliance for Regenerative Medicine
6:00-7:00pm | Networking & Cocktail Reception
Additional Events:
Please note this roundtable is held in conjunction with ARM’s Annual Dinner & Legislative Fly-In, also taking place May 24-25 in Washington DC. Attendees are encouraged to attend both events. See additional details HERE.
Event Location:
The St. Regis Washington DC
923 16th St., NW
Washington, DC 20006
More Information:
Chelsey Hathaway
Manager, Patient Advocacy & Events
chathaway@alliancerm.org
